<DOC>
	<DOCNO>NCT00373997</DOCNO>
	<brief_summary>The purpose study determine whether patient suspect Laryngopharyngeal reflux inflammation ultrastructural injury laryngeal biopsy .</brief_summary>
	<brief_title>Esophageal Laryngeal Tissue Changes Patients Suspected Having Laryngopharyngeal Reflux</brief_title>
	<detailed_description>Gastroesophageal reflux disease ( GERD ) implicate , part , cause various laryngeal sign symptom ( 1-7 ) . This often termed reflux laryngitis , ear , nose , throat ( ENT ) reflux , laryngopharyngeal reflux ( LPR ) . GERD first describe causative agent develop contact ulcer larynx ( 8 ) , since early report routinely observe laryngeal sign attribute LPR . These include laryngeal edema/erythema , vocal cord granuloma polyp , posterior cricoid cobblestoning , interarytenoid change , subglottic stenosis . In addition , patient symptom attribute LPR include hoarseness , sore burn throat , chronic cough , throat clearing , globus , nocturnal laryngospasm , otalgia , post-nasal drip , dysphagia . GERD occur 7 % - 25 % population daily monthly basis , respectively ( 9 ) . It estimate 10 % patient present ENT physician complaint think related LPR ( 2 ) . The current management patient suspect LPR complaint include either 1. empiric therapy use proton pump inhibitor ( PPI 's ) 2 . Ambulatory 24hour pH monitoring test GERD begin treatment . Because uncertainty subjectivity ENT laryngeal examination diagnose LPR , algorithms fall short ideal treat patient . In recent review literature , remarkably , 50 % patient laryngoscopic sign suggest LPR respond aggressive acid suppression abnormal esophageal acid reflux value pH test ( 10 ) . Yet , subset patient LPR continue implicate probable etiology patient laryngeal sign symptom . Calabrese , et al . recently look reversibility GERD related ultrastructural alteration esophagus use PPI . Lower esophageal biopsy analyze electron microscopy ( EM ) ultrastructural alteration attribute GERD ; , dilation intracellular space . Patients treat PPI re-biopsied analysis change heal may occur ultrastructural alteration . Not surprisingly , ultrastructural alteration show complete recovery ( reduction dilate intracellular space ) treatment PPI . Additionally resolution patient symptom coincide recovery ultrastructural alteration ( 11 ) . No biopsy look LPR related change larynx ever perform human subject . In sum , LPR extremely subjective diagnosis , nearly half patient abnormal 24hr pH study , respond standard GERD therapy acid suppression . Finding alternative objective criterion GERD induce laryngitis would important clinical discovery . To date , data microscopic change larynx patient suspect LPR . In sum , LPR extremely subjective diagnosis , nearly half patient abnormal 24hr pH study , respond standard GERD therapy acid suppression . To date , microscopic evidence laryngeal damage cause LPR .</detailed_description>
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Laryngopharyngeal Reflux</mesh_term>
	<mesh_term>Laryngeal Diseases</mesh_term>
	<criteria>Inclusion Criteria GERD 1 . Documented erosive esophagitis ( Patients newly diagnose esophageal erosion initial visit via esophagogastroduodenoscopy [ EGD ] ) 2.Patients nonerosive esophagitis responsive PPI LPR 1 . Diagnosed via Head &amp; Neck Institute endoscopists ( i.e . patient newly diagnose initial visit via laryngoscopy ) Controls 1 . No complaint history heartburn , acid regurgitation , atypical chest pain 2 . Never see GI ENT relate symptom 3 . No prior therapy GERD 4 . Have medical condition reflux need undergo EGD . These condition diarrhea , peptic ulcer disease , malabsorption , anemia , dysphagia . Exclusion Criteria Age &lt; 18yrs Pregnancy Patients contraindication EGD Use antacid ( PPI , H2RB ) within last 30 day Use any/all medication affect gastrointestinal motility Known history : Barrett 's esophagus , Peptic stricture , Pyloric stenosis , Gastric resection Patients unable give inform consent Patients unable comply followup Contraindications biopsy : Taking anticoagulant aspirin ( Coumadin , Plavix ) allergies local anesthetic .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2011</verification_date>
</DOC>